Moick Sigrid, Sommer Isolde, Gartlehner Gerald
Department für Evidenzbasierte Medizin und Evaluation, Universität für Weiterbildung Krems, Krems, Österreich.
Cochrane Österreich, Universität für Weiterbildung Krems, Krems, Österreich.
Gesundheitswesen. 2023 Feb;85(2):139-142. doi: 10.1055/a-1989-1745. Epub 2023 Feb 15.
Every year, more people die from cardiovascular diseases than from any other cause. Hypertension significantly increases the risk of heart, brain, kidney, and other diseases. The last World Health Organization (WHO) guideline on hypertension was published in 1999 and is now outdated.
The new WHO guideline of 2021 provides the most up-to-date recommendations for the pharmacological treatment of adult patients with hypertension. The aim of this study was to provide an overview of the WHO guideline translated into German and to summarize the main recommendations.
The guideline was developed by WHO in accordance with WHO standards. The executive summary was translated into German by the WHO Collaborating Centre for Evidence-based Medicine at the University of Continuing Education Krems (Austria).
WHO provides recommendations on blood pressure thresholds for initiating pharmacological treatment, the performance of examinations before initiating treatment, the choice of medication, target blood pressure, the frequency of assessments, and treatment by nonphysician professionals.
This evidence-based global public health guideline from WHO captures the most up-to-date key recommendations for the pharmacological treatment of hypertension in adults.
每年死于心血管疾病的人数比死于其他任何原因的都多。高血压会显著增加心脏、大脑、肾脏及其他疾病的风险。世界卫生组织（WHO）上一版关于高血压的指南于1999年发布，现已过时。
2021年WHO新指南为成年高血压患者的药物治疗提供了最新建议。本研究的目的是概述翻译成德语的WHO指南并总结主要建议。
该指南由WHO按照WHO标准制定。执行摘要由奥地利克雷姆斯继续教育大学的WHO循证医学合作中心翻译成德语。
WHO就启动药物治疗的血压阈值、治疗前检查的实施、药物选择、目标血压、评估频率以及非医师专业人员的治疗提供了建议。
WHO的这份基于证据的全球公共卫生指南涵盖了成年高血压患者药物治疗的最新关键建议。
